Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Satoshi Yokoi"'
Autor:
Satoshi Yokoi, Tsuyoshi Udagawa, Yusuke Fujioka, Daiyu Honda, Haruo Okado, Hirohisa Watanabe, Masahisa Katsuno, Shinsuke Ishigaki, Gen Sobue
Publikováno v:
Cell Reports, Vol 20, Iss 13, Pp 3071-3084 (2017)
FUS is an RNA-binding protein associated with frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Previous reports have demonstrated intrinsic roles of FUS in synaptic function. However, the mechanism underlying FUS’s
Externí odkaz:
https://doaj.org/article/9606a57fd0b143c7856045001dcee5b7
Autor:
Shinsuke Ishigaki, Yusuke Fujioka, Yohei Okada, Yuichi Riku, Tsuyoshi Udagawa, Daiyu Honda, Satoshi Yokoi, Kuniyuki Endo, Kensuke Ikenaka, Shinnosuke Takagi, Yohei Iguchi, Naruhiko Sahara, Akihiko Takashima, Hideyuki Okano, Mari Yoshida, Hitoshi Warita, Masashi Aoki, Hirohisa Watanabe, Haruo Okado, Masahisa Katsuno, Gen Sobue
Publikováno v:
Cell Reports, Vol 18, Iss 5, Pp 1118-1131 (2017)
Fused in sarcoma (FUS) and splicing factor, proline- and glutamine-rich (SFPQ) are RNA binding proteins that regulate RNA metabolism. We found that alternative splicing of the Mapt gene at exon 10, which generates 4-repeat tau (4R-T) and 3-repeat tau
Externí odkaz:
https://doaj.org/article/34d60d290c744f20bd7d1b9acc63952f
Autor:
Yuki Fukami, Masahiro Iijima, Koike, Haruki H., Satoru Yagi, Soma Furukawa, Naohiro Mouri, Jun Ouchida, Ayuka Murakami, Madoka Iida, Satoshi Yokoi, Atsushi Hashizume, Yohei Iguchi, Shiro Imagama, Masahisa Katsuno
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation; Mar2024, Vol. 11 Issue 2, p1-14, 14p
Autor:
Satoshi Yokoi, Takuji Ito, Kentaro Sahashi, Masahiro Nakatochi, Ryoichi Nakamura, Genki Tohnai, Yusuke Fujioka, Shinsuke Ishigaki, Tsuyoshi Udagawa, Yuishin Izumi, Mitsuya Morita, Osamu Kano, Masaya Oda, Takefumi Sone, Hideyuki Okano, Naoki Atsuta, Masahisa Katsuno, Yohei Okada, Gen Sobue
Publikováno v:
The Journal of Neuroscience. 42:8881-8896
Fused in sarcoma (FUS) is a pathogenic RNA-binding protein in amyotrophic lateral sclerosis (ALS). We previously reported that FUS stabilizes Synaptic Ras-GTPase activating protein 1 (Syngap1) mRNA at its 3′ untranslated region (UTR) and maintains
Autor:
Satoshi, Yokoi, Takuji, Ito, Kentaro, Sahashi, Masahiro, Nakatochi, Ryoichi, Nakamura, Genki, Tohnai, Yusuke, Fujioka, Shinsuke, Ishigaki, Tsuyoshi, Udagawa, Yuishin, Izumi, Mitsuya, Morita, Osamu, Kano, Masaya, Oda, Takefumi, Sone, Hideyuki, Okano, Naoki, Atsuta, Masahisa, Katsuno, Yohei, Okada, Gen, Sobue
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience. 42(47)
Fused in sarcoma (FUS) is a pathogenic RNA-binding protein in amyotrophic lateral sclerosis (ALS). We previously reported that FUS stabilizes Synaptic Ras-GTPase activating protein 1 (
Autor:
Satoshi Yokoi, Takuji Ito, Kentaro Sahashi, Masahiro Nakatochi, Ryoichi Nakamura, Genki Tohnai, Yusuke Fujioka, Shinsuke Ishigaki, Tsuyoshi Udagawa, Yuishin Izumi, Mitsuya Morita, Osamu Kano, Masaya Oda, Takefumi Sone, Hideyuki Okano, Naoki Atsuta, Masahisa Katsuno, Yohei Okada, Gen Sobue
Publikováno v:
Journal of Neuroscience; 11/23/2022, Vol. 42 Issue 47, p8881-8896, 16p
Autor:
Naoki Suzuki, Masashi Aoki, Kuniyuki Endo, Keiko Mori, Gen Sobue, Hitoshi Warita, Yuichi Riku, Satoshi Yokoi, Akio Akagi, Kaori Kawai, Minaka Ishibashi, Yusuke Fujioka, Nobuyuki Iwade, Shinsuke Ishigaki, Hirohisa Watanabe, Osamu Yokota, Ito Kawakami, Mari Yoshida, Seishi Terada, Masahisa Katsuno
Publikováno v:
Brain
Fused in sarcoma (FUS) is genetically and clinicopathologically linked to frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). We have previously reported that intranuclear interactions of FUS and splicing factor, proline
Autor:
Akiko Uchida, Satoshi Yokoi, Masayuki Kato, Yasushi Isobe, Yasuyuki Inoue, Yuka Tsuruoka, Hirotaka Sakai, Manabu Matsunawa, Yuji Nishio, Yoshinori Suzuki, Yu Uemura, Yusuke Saiki, Ikuo Miura, Kazuyuki Sato, Naoto Tomita
Publikováno v:
International Journal of Hematology. 108:274-281
The introduction of all-trans retinoic acid (ATRA) has made acute promyelocytic leukemia (APL) a curable disease; however, early death prior to the completion of treatment remains a problem. In quantitative evaluation of response to ATRA treatment, l
Autor:
Gen Sobue, Tsuyoshi Udagawa, Shinsuke Ishigaki, Satoshi Yokoi, Daiyu Honda, Yusuke Fujioka, Masahisa Katsuno, Haruo Okado, Hirohisa Watanabe
Publikováno v:
Cell Reports, Vol 20, Iss 13, Pp 3071-3084 (2017)
FUS is an RNA-binding protein associated with frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Previous reports have demonstrated intrinsic roles of FUS in synaptic function. However, the mechanism underlying FUS's re
Autor:
Kuniyuki Endo, Masashi Aoki, Gen Sobue, Hitoshi Warita, Yusuke Fujioka, Tsuyoshi Udagawa, Mari Yoshida, Hideyuki Okano, Yohei Iguchi, Shinsuke Ishigaki, Yohei Okada, Daiyu Honda, Hirohisa Watanabe, Akihiko Takashima, Masahisa Katsuno, Shinnosuke Takagi, Haruo Okado, Kensuke Ikenaka, Yuichi Riku, Satoshi Yokoi, Naruhiko Sahara
Publikováno v:
Cell Reports, Vol 18, Iss 5, Pp 1118-1131 (2017)
Fused in sarcoma (FUS) and splicing factor, proline- and glutamine-rich (SFPQ) are RNA binding proteins that regulate RNA metabolism. We found that alternative splicing of the Mapt gene at exon 10, which generates 4-repeat tau (4R-T) and 3-repeat tau